Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Carol Fabian, MD
With
Intergenetics, Inc.
A study to examine the correlation between single nucleotide polymorphisms (SNPs) affecting steroid and carcinogen metabolism and benign breast tissue cytomorphology collected via random periareolar fine needle aspiration in postmenopausal women at increased risk for breast cancer and taking hormone replacement therapy.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
postmenopausal women on or off hormone replacement therapy
at high risk of developing breast cancer determined by family or personal history
postmenopausal women not on hormone replacement therapy for at minimum six months prior to corresponding aspiration
willing to participate in companion protocol (KUMC HSC#4601) for random periareolar fine needle aspiration (RPFNA) for correlational studies
You may not be if
women who have been on raloxifene, tamoxifen, letrozole, anastrozole or exemestane within the six months prior to RPFNA.
Clareo Health | Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer
